Yew Bio-Pharm Group Inc (YEWB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 110 | 14,844 | 8,737 | 5,361 | 10,355 |
| Cost of Goods | 950 | 15,072 | 7,780 | 5,087 | 8,830 |
| Gross Profit | -840 | -228 | 957 | 274 | 1,525 |
| Operating Expenses | 1,668 | 274 | -1,229 | 301 | 861 |
| Operating Income | -1,558 | -431 | 2,967 | 61 | 1,494 |
| Other Income | 0 | -115 | -55 | -479 | -471 |
| Pre-tax Income | -1,559 | -546 | 2,912 | -419 | 1,023 |
| Income Tax | N/A | -2 | N/A | 2 | 27 |
| Net Income Continuous | -1,559 | -544 | 2,912 | -420 | 996 |
| Minority Interests | -8 | 3 | -6 | N/A | N/A |
| Net Income | $-1,550 | $-550 | $2,918 | $-420 | $996 |
| EPS Basic Total Ops | -0.03 | -0.01 | 0.06 | N/A | 0.02 |
| EPS Basic Continuous Ops | -0.03 | -0.01 | 0.06 | -0.01 | 0.02 |
| EPS Diluted Total Ops | -0.03 | -0.01 | 0.06 | N/A | 0.02 |
| EPS Diluted Continuous Ops | -0.03 | -0.01 | 0.06 | -0.01 | 0.02 |
| EPS Diluted Before Non-Recurring Items | -0.03 | -0.01 | N/A | N/A | 0.02 |
| EBITDA(a) | $-889 | $303 | $3,650 | $792 | $2,291 |